Impact of alcohol drinking and tobacco smoking on the drug-resistance of newly diagnosed tuberculosis: a retrospective cohort study in Shandong, China, during 2004-2020
Wan-mei Song,Shi-jin Li,Jin-yue Liu,Qi Fu,Ting-ting Xu,Ning Ning Tao,Qian-yun Zhang,Si-qi Liu,Qi-qi An,Xue-han Zhu,Yao Liu,Chun-bao Yu,Yi-fan Li,Jihua Dong,Huai-chen Li
DOI: https://doi.org/10.1136/bmjopen-2021-059149
IF: 3.006
2022-07-29
BMJ Open
Abstract:Objectives To investigate the independent and collective impact of alcohol drinking and tobacco smoking on the drug-resistance of newly diagnosed tuberculosis (TB). Design This was a retrospective cohort study. Setting Shandong, China. Participants Patients with newly diagnosed TB from 1 January 2004 to 31 December 2020 were collected. Exclusive criteria: retreated cases; extrapulmonary tuberculosis; without information on drug susceptibility testing results, smoking or drinking habits; bacteriological identification as non-tuberculous mycobacteria . Primary and secondary outcome measures Patients were classified into four groups including smokers only (G 1 ), drinker only (G 2 ), smoker +drinker (G 3 ), non-smoker +non-drinker group (G 0 ). We described the drug-resistant profiles, clinical factors and calculated the ORs of different drug-resistance among G 1 , G 2 , G 3 , compared with G 0 through univariate and multivariate logistics regression models. Results Of the 7996 TB cases enrolled, the proportions of G 1 , G 2 , G 3 and G 0 were 8.25%, 3.89%, 16.46% and 71.40%, respectively. The rates of drug-resistant (DR)-TB, mono-resistant TB, multidrug resistant (MDR)-TB, polydrug resistant TB in G 1, G 2 , G 3 and G 0 were 19.24%/16.4%/17.33%/19.08%, 11.52%/8.68%/10.94%/11.63%, 3.03%/2.57%/2.96%/3.66% and 4.70%/4.82%/3.34%/ 4.08%, respectively. G 3 had a higher risk of MDR1: isoniazid +rifampin (adjusted OR (aOR)=1.91, 95% CI: 1.036 to 3.532), but had a lower risk of DR-TB (aOR=0.84, 95% CI: 0.71 to 0.99), rifampin-related resistance (aOR=0.68, 95% CI: 0.49 to 0.93), streptomycin-related resistance (aOR=0.82, 95% CI: 0.68 to 0.99), ethambutol-related resistance (aOR=0.57, 95% CI: 0.34 to 0.95), MDR3: isoniazid +rifampin+streptomycin (aOR=0.41, 95% CI: 0.19 to 0.85), any isoniazid +streptomycin resistance (aOR=0.85, 95% CI: 0.71 to 1.00). However, there were no significant differences between G 1 and G 0 , G 2 and G 0 in all drug-resistant subtypes. Those patients with cavity had a higher risk of DR-TB among G 3 (OR=1.35, 95% CI: 1.01 to 1.81). Conclusion Although we did not found an independent impact of alcohol drinking or tobacco smoking on TB drug-resistance, respectively, these two habits had a combined effect on TB drug-resistance.
medicine, general & internal